On the mechanisms by which theophylline changes core body temperature in mice.
暂无分享,去创建一个
[1] L. Paalzow,et al. Theophylline increased sensitivity to nociceptive stimulation and regional turnover of rat brain 5-HT, noradrenaline and dopamine. , 2009, Acta pharmacologica et toxicologica.
[2] M. Durcan,et al. Opioid receptor mediation of the hypothermic response to caffeine. , 1992, European journal of pharmacology.
[3] M. Durcan,et al. Hypothermic effects of alkylxanthines: evidence for a calcium-independent phosphodiesterase action. , 1991, European journal of pharmacology.
[4] M. Jensen,et al. Effects of long-term coenzyme Q10 and captopril treatment on survival and functional capacity in rats with experimentally induced heart infarction. , 1990, The Journal of pharmacology and experimental therapeutics.
[5] M. Reddington,et al. Both A1 and A2a Purine Receptors Regulate Striatal Acetylcholine Release , 1990, Journal of neurochemistry.
[6] L. Pohorecky,et al. Alteration of the effects of caffeine by prenatal stress , 1989, Pharmacology Biochemistry and Behavior.
[7] S. Ferré,et al. Relationship between rotational behaviour induced by apomorphine and caffeine in rats with unilateral lesion of the nigrostriatal pathway , 1989, Neuropharmacology.
[8] W. Boyar,et al. Inhibition of nigrostriatal release of dopamine in the rat by adenosine receptor agonists: A1 receptor mediation , 1989, Neuropharmacology.
[9] G. Lu,et al. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. , 1986, Molecular pharmacology.
[10] T. Seale,et al. Sensitivity of inbred mice to methylxanthines is not determined by plasma xanthine concentration , 1985, Neuroscience Letters.
[11] J. C. Stoof,et al. Two dopamine receptors: biochemistry, physiology and pharmacology. , 1984, Life sciences.
[12] J. Hyttel. Functional evidence for selective dopamine D-1 receptor blockade by SCH 23390 , 1984, Neuropharmacology.
[13] A. Schlosberg. Temperature responses in rats after acute and chronic administrations of caffeine , 1983, Pharmacology Biochemistry and Behavior.
[14] E. Spindel,et al. Neuroendocrine effects of caffeine. II. Effects on thyrotropin and corticosterone secretion. , 1983, The Journal of pharmacology and experimental therapeutics.
[15] J. Daly. Adenosine receptors: targets for future drugs. , 1982, Journal of medicinal chemistry.
[16] J. Fernstrom,et al. Acute effects of caffeine injection on neutral amino acids and brain monoamine levels in rats. , 1981, Life sciences.
[17] T. Stone. Physiological roles for adenosine and adenosine 5′-triphosphate in the nervous system , 1981, Neuroscience.
[18] H. Watanabe,et al. Properties of rotational behaviour produced by methylxanthine derivatives in mice with unilateral striatal 6-hydroxydopamine-induced lesions. , 1981, Journal of pharmacobio-dynamics.
[19] M. Lin,et al. The effects of theophylline and caffeine on thermoregulatory functions of rats at different ambient temperatures , 1980, The Journal of pharmacy and pharmacology.
[20] H. H. Harms,et al. Effects of adenosine on depolarization-induced release of various radiolabelled neurotransmitters from slices of rat corpus striatum , 1979, Neuropharmacology.
[21] Estler Cj. Failure of phenoxybenzamine and pimozide to diminish changes in oxygen consumption and body temperature produced by caffeine. , 1979 .
[22] H. H. Harms,et al. Adenosine modulates depolarization-induced release of 3H-noradrenaline from slices of rat brain neocortex. , 1978, European journal of pharmacology.
[23] G. Chiara,et al. Evidence for dopamine receptors mediating sedation in the mouse brain , 1976, Nature.
[24] G. Curzon,et al. EFFECT OF AMINOPHYLLINE ON TRYPTOPHAN AND OTHER AROMATIC AMINO ACIDS IN PLASMA, BRAIN AND OTHER TISSUES AND ON BRAIN 5‐HYDROXYTRYPTAMINE METABOLISM , 1976, British journal of pharmacology.
[25] K. Fuxe,et al. Effect of some phosphodiesterase inhibitors on central dopamine mechanisms. , 1976, European journal of pharmacology.
[26] G. Arbuthnott,et al. Is adenylate cyclase the dopamine receptor? , 1974, Medical biology.
[27] U. Ungerstedt,et al. Action of caffeine and theophyllamine on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with DOPA and dopamine receptor agonists. , 1974, Medical biology.
[28] K Fuxe,et al. Effects of caffeine on central monoamine neurons , 1972, The Journal of pharmacy and pharmacology.
[29] J R Gillette,et al. Effects of Caffeine and Theophylline on Activity of Rats in Relation to Brain Xanthine Concentrations 1 , 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[30] B A Berkowitz,et al. The interaction of caffeine, theophylline and theobromine with monoamine oxidase inhibitors. , 1971, European journal of pharmacology.
[31] B A Berkowitz,et al. The effect of caffeine and theophylline on the disposition of brain serotonin in the rat. , 1971, European journal of pharmacology.
[32] B Waldeck,et al. Some effects of caffeine and aminophylline on the turnover of catecholamines in the brain , 1971, The Journal of pharmacy and pharmacology.
[33] B A Berkowitz,et al. Release of norepinephrine in the central nervous system by theophylline and caffeine. , 1970, European journal of pharmacology.
[34] J. Patkowski,et al. Proteolytic activity, its inhibitors, and the blastic reaction in graft rejection , 1969, The Journal of pharmacy and pharmacology.
[35] A. Owji,et al. Evaluation of dopamine receptor involvement in rat feeding behaviour. , 1991, General pharmacology.
[36] S. Nelson,et al. Effect of methylxanthines on acetaminophen hepatotoxicity in various induction states. , 1990, The Journal of pharmacology and experimental therapeutics.
[37] J. Daly,et al. Caffeine and theophylline analogues: correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors. , 1988, Life sciences.
[38] G. Rebec. Electrophysiological Pharmacology of Amphetamine1 , 1987 .
[39] T. Dunwiddie. The physiological role of adenosine in the central nervous system. , 1985, International review of neurobiology.